Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 5th Targeted Radiopharmaceuticals Summit US 2026.

Pharma Executives

C-Suite Standouts

Alexander Schinagl - Co-Founder & Chief Technology Officer, OncoOne - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Alexander Schinagl

Alison Armour

Alison Armour

Ben Hickey - President, Rayzebio - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Ben Hickey

Ben Pais - Chief Medical Officer Nuclidium - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Ben Pais

Benjamin Titz - Co-Founder and Chief Executive Officer, Alkyon Therapeutics - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Benjamin Titz

Caitlyn Miller - Co-Founder & Chief Executive Officer, TwoStep Therapeutics - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Caitlyn Miller

Cheryl Maley - Chief Executive Officer, Starpharma Ltd - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Cheryl Maley

Chris Pak - CEO, Molecular Targeting Technologies - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Chris Pak

Chris Adams

Christopher Adams

Dan Stevens - Chief Medical Officer, Blue Earth Therapeutics Ltd - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Dan Stevens

Dirk Pleimes

Dirk Pleimes

Jessica Guarnaschelli - Independent Consultant, CURADH Pharmaceuticals - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Jessica Guarnaschelli

John babich - President & Chief Scientific Officer, Ratio Therapeutics, Inc - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

John Babich

Jose Zayas - Quality Assurance & Regulatory Affairs & Radiopharmaceuticals Chemistry, manufacturing & controls Consultant, Zaycor Industries Corp - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Jose Zayas

Julian Rees - Co-Founder & Chief Executive Officer, HOPO Therapeutics - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Julian Rees

Kawa Chiu

Kawa Chiu

Kyle Hoffmann - Director - Manufacturing Operations & Co-Founder, Juniper Biosciences - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Kyle Hoffmann

Michael Groaning - Chief Scientific Officer, Soricimed Biopharma Inc - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Michael Groaning

Michel Afargan - Chief Scientific Officer, Head Drug Developments and Radiopharmaceutical Strategies, Starget Pharma - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Michel Afargan

Munir Ghesani - 4th TRP Summit

Munir Ghesani

Olga Issakova - Chief Operating Officer, Tailor Therapeutics - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Olga Issakova

Phillip Davis - Chief Executive Officer, Ex-FDA - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Phillip Davis

Ramzi Amri - Chief Financial Officer, Oncoinvent AS - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Ramzi Amri

Riccardo Canevari - Chief Executive Officer, RadioPharm Theranostics - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

Riccardo Canevari

Richard Messmann

Rich Messmann

THOMAS TULIP - Principal, RadioPharm OGs - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

THOMAS TULIP

Biotech Innovators

Academic All-Stars

Partner Speakers

TRP Conference Image
Explore the Agenda

Discover how leading scientists and clinicians in TRP and radioligand therapy are redefining every stage of development - from target discovery and validation to isotope selection and commercialization strategy. Gain insight into the approaches shaping the next generation of radiopharmaceutical therapies and accelerating their path to the clinic.

TRP Conference Image
Partner With Us

Engage directly with key decision-makers across imaging, radiochemistry, isotope development and more, who are actively seeking collaborations. Explore opportunities to accelerate the development of safer, more effective radiopharmaceuticals and contribute to projects that move quickly from concept to clinical application.

TRP Conference Image
Join TRP Experts

Network with over 260 radiochemists, biologists, clinicians, and R&D leaders who are shaping the full RLT pipeline. Share expertise, exchange ideas, and collaborate across discovery, preclinical development, and clinical translation to advance therapies that can make a real impact for patients.